Market Size of Global Digital Breast Tomosynthesis Equipment Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 3.34 Billion |
Market Size (2029) | USD 6.37 Billion |
CAGR (2024 - 2029) | 13.83 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Digital Breast Tomosynthesis Equipment Market Analysis
The Global Digital Breast Tomosynthesis Equipment Market size is estimated at USD 3.34 billion in 2024, and is expected to reach USD 6.37 billion by 2029, growing at a CAGR of 13.83% during the forecast period (2024-2029).
COVID-19 outbreak has significantly impacted the Digital Breast Tomosynthesis Equipment Market during the pandemic period. The pandemic resulted in substantial reductions in breast cancer screening, cancer management visits, and cancer procedures across the globe. For instance, a study published in the Journal of the American College of Radiology in June 2022 stated that cancer diagnoses dropped by nearly 50% in the peak-pandemic period and have not entirely rebounded to the pre-COVID rate. The strict lockdown and the policies led to the relocation of medical healthcare providers and material resources, which led the healthcare providers to focus primarily on this abrupt pandemic emergency, thereby postponing other non-emergency medical services such as digital breast tomosynthesis. However, the relaxation of the lockdown restrictions and the resumption of cancer diagnostics during the post-pandemic period are expected to contribute to the market's growth.
The growth factors expected to drive the market are the increasing prevalence of breast cancer worldwide, technological advancements in the field of breast imaging, and rising awareness about the use of digital breast tomosynthesis (DBT). The increasing prevalence of breast cancer cases is expected to drive the demand for advanced diagnosis, fueling the studied market. For instance, the article published in MDPI in July 2022 mentioned that 45.4% of breast cancer cases were diagnosed in Asia in 2021. Additionally, the Breast Cancer Organization data published in August 2022 mentioned that breast cancer is the most common cancer globally, accounting for 12.5% of cancer cases annually. The report also mentioned that it is estimated that about 30% of all diagnosed cancer in women might be breast cancer in 2022. The rising prevalence of breast cancer is expected to drive the demand for digital breast tomosynthesis equipment owing to the advanced diagnosis, thereby contributing to the market's growth.
On the other hand, the increasing product launches by various key market players is also expected to contribute to the market's growth over the forecast period. For instance, in August 2021, FUJIFILM Medical Systems launched its ASPIRE Cristalle mammography system with Digital Breast Tomosynthesis (DBT) that offers ScreenPoint Medical's new, US FDA-cleared Transpara powered by Fusion Artificial Intelligence (AI) for 2D and 3D mammography in the United States. Moreover, rising awareness campaigns by various organizations working towards spreading awareness about breast cancer are expected to play a vital role in the market's growth. For instance, in October 2021, the Pink Bot breast cancer awareness campaign was initiated with a chat module integrated to answer queries on breast cancer, the latest initiative from Dr. P Guhan and his team to raise awareness of it. Similarly, in May 2022, Mount Sinai Health System initiated Mammogram May to empower women to take charge of their breast health by scheduling an annual mammogram. The goals of the campaign are to raise awareness of the importance of mammography in early breast cancer detection and treatment and to address a decline in breast screenings worsened by the pandemic.
Thus, due to the aforesaid mentioned reasons, the market is expected to show significant growth over a forecast period. However, the high costs of the systems and side effects associated with radiation exposure may slow down its growth over the forecast period.
Digital Breast Tomosynthesis Equipment Industry Segmentation
As per the scope of the report, Digital Breast Tomosynthesis (DBT) or 3D mammography is an advanced mammography that uses low-dose x-rays to detect cancer early when it is most treatable. The digital breast tomosynthesis equipment market is segmented by Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems), End-Users (Hospitals, Diagnostic Centers, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.
By Product Type | |
2D/3D Combination Mammography Systems | |
Standalone 3D Mammography Systems |
By End-User | |
Hospitals | |
Diagnostic Centers | |
Other End-Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Digital Breast Tomosynthesis Equipment Market Size Summary
The digital breast tomosynthesis equipment market is poised for significant growth over the forecast period, driven by the increasing prevalence of breast cancer globally and advancements in breast imaging technology. The market, which experienced a downturn during the COVID-19 pandemic due to reduced screening and diagnostic procedures, is expected to recover as healthcare services resume normal operations. The rising awareness of digital breast tomosynthesis and its benefits in early cancer detection is further propelling market expansion. Key players in the industry are actively launching innovative products, such as Fujifilm's ASPIRE Cristalle system, which integrates advanced artificial intelligence for enhanced mammography. These developments, coupled with awareness campaigns like Mammogram May, are expected to bolster market growth.
North America is anticipated to dominate the digital breast tomosynthesis equipment market, supported by a high demand for advanced diagnostic solutions and a significant burden of breast cancer cases. The region's market growth is fueled by ongoing research and development, technological advancements, and new product introductions by major players such as Hologic, Inc. and GE Healthcare. The introduction of products like iCAD's ProFound AI for DBT highlights the region's commitment to improving breast cancer detection and diagnosis. Despite the high costs and potential side effects associated with radiation exposure, the market's growth trajectory remains strong, driven by the efficacy of 2D/3D combination mammography systems and the continuous innovation in diagnostic technologies.
Global Digital Breast Tomosynthesis Equipment Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Breast Cancer Worldwide
-
1.2.2 Technological Advancements in the Field of Breast Imaging
-
1.2.3 Rising Awareness About the Use of Digital Breast Tomosynthesis (DBT)
-
-
1.3 Market Restraints
-
1.3.1 High Costs of the Systems
-
1.3.2 Side Effects Associated with Radiation Exposure
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 2D/3D Combination Mammography Systems
-
2.1.2 Standalone 3D Mammography Systems
-
-
2.2 By End-User
-
2.2.1 Hospitals
-
2.2.2 Diagnostic Centers
-
2.2.3 Other End-Users
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Digital Breast Tomosynthesis Equipment Market Size FAQs
How big is the Global Digital Breast Tomosynthesis Equipment Market?
The Global Digital Breast Tomosynthesis Equipment Market size is expected to reach USD 3.34 billion in 2024 and grow at a CAGR of 13.83% to reach USD 6.37 billion by 2029.
What is the current Global Digital Breast Tomosynthesis Equipment Market size?
In 2024, the Global Digital Breast Tomosynthesis Equipment Market size is expected to reach USD 3.34 billion.